Ryan J. Malone, MD, presented “Using the Level 2 Next Generation Sequencing Report for Recurrent UTI Patients” for the Grand Rounds in Urology audience in April 2021.
How to cite: Malone, Ryan J. “Using the Level 2 Next Generation Sequencing Report for Recurrent UTI Patients” April 2021. Accessed Jul 2024. https://grandroundsinurology.com/using-the-level-2-next-generation-sequencing-report-for-recurrent-uti-patients/
Using the Level 2 Next Generation Sequencing Report for Recurrent UTI Patients – Summary:
A. Lenore Ackerman, MD, Assistant Professor of Surgery, Urology and Pelvic Medicine and Reconstructive Surgery at Cedars-Sinai Medical Center, interviews Ryan J. Malone, MD, Urologist at First Urology in Jeffersonville, Indiana, about using microbial DNA diagnostics in a clinical context for recurrent UTI. They address how next generation sequencing (NGS) gleans resistance gene data, which patients benefit most, the collection process, ease of use, and patient response. Additionally, they analyze a sample Level 2 report for recurrent UTI patients and discuss how its data can guide treatment.
For more in-depth discussions and educational features on NGS, visit our Microbiome & Urologic Infection Learning Center.
ABOUT THE AUTHOR
Dr. Malone hails from Murray, Kentucky, where he received his undergraduate degree from Murray State University. He went on to earn his MD from the University of Louisville School of Medicine.
Dr. Malone completed his surgical internship and urology residency at Ohio State University Medical Center in Columbus, Ohio, then spent three years in private practice in Savannah, Georgia, before joining Allied Urology, now First Urology, PSC, in 2008.
Dr. Malone’s interests include all aspects of urology, specifically laparoscopic urologic surgery, urinary stone disease, female urology, urinary incontinence, bladder dysfunction, urologic oncology, and the treatment of BPH. He is certified by the American Board of Urology and is licensed to practice medicine in Kentucky, Indiana, Ohio, and Georgia.
